Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Anti-VEGF")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1198

  • Page / 48
Export

Selection :

  • and

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agentsGOOD, Travis J; KIMURA, Alan E; MANDAVA, Naresh et al.British journal of ophthalmology. 2011, Vol 95, Num 8, pp 1111-1114, issn 0007-1161, 4 p.Article

Anti-vascular endothelial growth factor agents for diabetic maculopathySALAM, A; DACOSTA, J; SIVAPRASAD, S et al.British journal of ophthalmology. 2010, Vol 94, Num 7, pp 821-826, issn 0007-1161, 6 p.Article

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Due to Sorsby Macular DystrophyKAPOOR, Kapil G; BAKRI, Sophie J.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 4, pp 444-447, issn 1080-7683, 4 p.Article

Effects of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Exudative Age-Related Macular DegenerationSUNG JUN LEE; HYOUNG JUN KOH.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 1, pp 101-110, issn 0161-6420, 10 p.Article

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment EfficacyBAGRI, Anil; BERRY, Leanne; ROSEN, Oliver et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3887-3900, issn 1078-0432, 14 p.Article

Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office SettingPILLI, Suman; KOTSOLIS, Athanasios; SPAIDE, Richard F et al.American journal of ophthalmology. 2008, Vol 145, Num 5, pp 879-882, issn 0002-9394, 4 p.Article

Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor AgentsKIM, Judy E; MANTRAVADI, Anand V; HUR, Elizabeth Y et al.American journal of ophthalmology. 2008, Vol 146, Num 6, pp 930-934, issn 0002-9394, 5 p.Article

Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsHOANG, Quan V; MENDONCA, Luis S; DELLA TORRE, Kara E et al.Ophthalmology (Rochester, MN). 2012, Vol 119, Num 2, pp 321-326, issn 0161-6420, 6 p.Article

Anti―Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration SurgeryMATHEW, Rashmi; BARTON, Keith.American journal of ophthalmology. 2011, Vol 152, Num 1, pp 10-15, issn 0002-9394, 6 p.Article

Anti-Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related TumorsHON KIT WONG; LAHDENRANTA, Johanna; KAMOUN, Walid S et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 9, pp 3483-3493, issn 0008-5472, 11 p.Article

Ocular Hypertension Following Intravitreal Anti-vascular Endothelial Growth Factor AgentsSINGH, Ravi S. J; KIM, Judy E.Drugs & aging. 2012, Vol 29, Num 12, pp 949-956, issn 1170-229X, 8 p.Article

Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the TargetSITOHY, Basel; NAGY, Janice A; DVORAK, Harold F et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 8, pp 1909-1914, issn 0008-5472, 6 p.Article

Retinal Nerve Fiber Layer Thickness in Patients Receiving Chronic Anti-Vascular Endothelial Growth Factor TherapyHORSLEY, Michael B; MANDAVA, Naresh; MAYCOTTE, Marco A et al.American journal of ophthalmology. 2010, Vol 150, Num 4, pp 558-561, issn 0002-9394, 4 p.Article

Néovaisseaux choroïdiens associés aux stries angidïdes et traitement par anti-VEGF = Intravitreal anti-VEGF treatment of choroidal neovascularisation in patients with angioid streaksNGHIEM-BUFFET, S; QUENTEL, G.Images en ophtalmologie. 2009, Vol 3, Num 2, pp 50-53, issn 1961-3172, 4 p.Article

Suspected Bacterial Endophthalmitis following Intravitreal Anti-VEGF Injection: Case Series and Literature ReviewHOEVENAARS, N. E. D; GANS, D; MISSOTTEN, T et al.Ophthalmologica (Basel). 2012, Vol 228, Num 3, pp 143-147, issn 0030-3755, 5 p.Article

❸ Actualités en oncologie digestive Anti-angiogéniques en 2e et 3e lignesDES GUETZ, Gaëtan.Onko +. 2012, Vol 4, Num 31, pp 155-156, issn 2101-9495, 2 p.Conference Paper

DMLA: les traitements à venir = AMD: Future therapiesCOHEN, S. Y; GIRMENS, J.-F.Journal français d'ophtalmologie. 2011, Vol 34, Num 7, pp 498-501, issn 0181-5512, 4 p.Conference Paper

Traitement du glaucome néovasculaire lié à la persistance après chirurgie du décollement de rétine d'un décollement de rétine périphérique annulaire = Management of neovascular glaucoma related to the persistence after retinal detachment surgery of a circumferential peripheral retinal detachmentDELAUNAY-SUPLY, A.-C; COCHENER, B; GAMBRELLE, J et al.Journal français d'ophtalmologie. 2011, Vol 34, Num 10, pp 711-714, issn 0181-5512, 4 p.Conference Paper

Traitement du glaucome néovasculaire en 2012: apport des anti-VEGF = Neovascular glaucoma treatment in 2012: Role of anti-VEGF agentsKODJIKIAN, L.Journal français d'ophtalmologie. 2013, Vol 36, Num 5, pp 461-465, issn 0181-5512, 5 p.Conference Paper

Traitement des néovaisseaux choroïdiens de la myopie forte: recommandations de la Fédération France Macula = Treatment of myopic choroidal neovascularization: Recommendations of the Fédération France MaculaLEVEZIEL, N; QUARANTA-EL MAFTOUHI, M; LALLOUM, F et al.Journal français d'ophtalmologie. 2014, Vol 37, Num 4, pp 320-328, issn 0181-5512, 9 p.Article

On the use of antiangiogenetic medications for retinopathy of prematurityHARD, Anna-Lena; HELLSTRÖM, Ann.Acta paediatrica (Oslo). 2011, Vol 100, Num 8, pp 1063-1065, issn 0803-5253, 3 p.Article

DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In VivoLI, Ji-Liang; SAINSON, Richard C. A; WU, Herren et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 18, pp 6073-6083, issn 0008-5472, 11 p.Article

Management of hypertension in angiogenesis inhibitor-treated patientsIZZEDINE, H; EDERHY, S; GOLDWASSER, F et al.Annals of oncology. 2009, Vol 20, Num 5, pp 807-815, issn 0923-7534, 9 p.Article

Œdème maculaire: injection intravitréenne d'anti-VEGF et médicaments apparentés: À quoi servent-il ?PAGOT-MATHIS, Véronique.Diabète & obésité. 2014, Vol 9, Num 77, pp 92-96, issn 1957-5238, 5 p.Article

Œdème maculaire: injection intravitréenne d'anti-VEGF et médicaments apparentés: À quoi servent-il ?PAGOT-MATHIS, Véronique.Pratiques en ophtalmologie. 2014, Vol 8, Num 73, pp 74-78, issn 2106-9735, 5 p.Article

  • Page / 48